ebook Munafa Stock Market Course + Intraday & FNO calls  

       

VENUSREM announcements Venus Remedies Limited announcements and dividends declared NSE

Venus Remedies Limited Complete list of announcements declared & dividend announcements by Venus Remedies Limited VENUSREM

Venus Remedies Limited VENUSREM listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Venus Remedies Limited VENUSREM

Venus Remedies gains 4% on Philippine nod to market 6 chemotherapy drugs
Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines movement for another 45 marketing authorisations, and most of these pending approvals are for oncology product.
Announcement as on 16 October 2023

Venus Remedies zooms 20%; gets nod for 6 chemotherapy drugs in Philippines
The company has secured marketing authorisation for bortezomib cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel from the Philippines.
Announcement as on 16 October 2023

Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines
Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines for additional 45 marketing authorisations, and most of these pending approvals are for oncology products, it said. Pertinently, the market size of cancer drugs in the
Announcement as on 16 October 2023

Venus Remedies trades 2% up on approval to market cancer drugs in Serbia
"The company has secured marketing authorisation from Serbia for gemcitabine and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer," the company said in a regulatory filing.
Announcement as on 20 September 2023

Venus Remedies gains on registering with govt body; to get custom duty exemption
"This exemption will not only enable us to reduce production costs but also empower us to invest more in research and development, enhancing our competitiveness and expanding our global reach," said Saransh Chaudhary, chief of research at Venus Remedies.
Announcement as on 14 September 2023

Announcements by Venus Remedies Limited first page | Next page | Prev page |

VENUSREM Venus Remedies Limited current price & indicator signals

Moving Averages for Venus Remedies Limited

  • 5Day Average: 702.47
  • 12Day Average: 662.14
  • 20Day Average: 591.11
  • 50Day Average: 505.43
  • 100Day Average: 429.71
  • 150Day Average: 387.34
  • 200Day Average: 368.5

VENUSREM Indicators & signals

Indicator MACD (12,26,9)

660.43, 591.92, 57.91
Indicator MACD is in positive zone

Indicator ADX (14)

61.71, 38.65, 9.15
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 68
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of VENUSREM Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Mon Dec 2025 727.05 665.30 to 748.85 5.19% 0.73 times
28 Fri Nov 2025 691.15 685.85 to 724.90 -3.92% 0.33 times
27 Thu Nov 2025 719.35 688.00 to 758.00 3.13% 1.2 times
26 Wed Nov 2025 697.50 657.40 to 699.00 2.98% 0.45 times
25 Tue Nov 2025 677.30 647.35 to 725.00 -5.52% 0.67 times
24 Mon Nov 2025 716.90 696.15 to 728.95 2.28% 0.73 times
21 Fri Nov 2025 700.95 680.10 to 725.00 1.72% 1.22 times
20 Thu Nov 2025 689.10 656.35 to 707.05 6.86% 1.91 times
19 Wed Nov 2025 644.85 554.05 to 665.85 16.21% 3.05 times
18 Tue Nov 2025 554.90 550.00 to 569.80 0.02% 0.2 times
17 Mon Nov 2025 554.80 552.00 to 579.45 -2.98% 0.22 times
14 Fri Nov 2025 571.85 557.50 to 576.00 1.46% 0.29 times

Videos related to: VENUSREM announcements Venus Remedies Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

VENUSREM announcements Venus Remedies Limited announcements and dividends declared NSE

 

Back to top